Skip to main content
. 2015 Sep 24;6(32):32774–32789. doi: 10.18632/oncotarget.5192

Figure 4. Reduced miR-134 levels are found in breast tumour and serum EV specimens, compared to healthy controls.

Figure 4

Analysis of the GEO datasets A. GSE26659 and B. GSE40525 showed that miR-134 is significantly down-regulated in breast tumours when compared to levels in healthy control breast tissue. Graphs are displayed as mean ± SEM, where ***p < 0.001.